European Companies Search Engine
EU funding (€14.9M): Ubiquitous Pharmacogenomics (U-PGx): Making actionable pharmacogenomic data and effective treatment optimization accessible to every European citizen Hor1 Jan 2016 EU Research and Innovation programme "Horizon"
Overview
Text
Ubiquitous Pharmacogenomics (U-PGx): Making actionable pharmacogenomic data and effective treatment optimization accessible to every European citizen
Pharmacogenomics is the study of genetic variability affecting an individual’s response to a drug. Its use allows personalized medicine and reduction in ‘trial and error’ prescribing leading to more efficacious, safer and cost-effective drug therapy. The U-PGx consortium will investigate a pre-emptive genotyping approach (that is: multiple pharmacogenomic variants are collected prospectively and embedded into the patients’ electronic record) of a panel of important pharmacogenomic variants as a new model of personalised medicine. To meet this goal we combine existing pharmacogenomics guidelines and novel health IT solutions. Implementation will be conducted at a large scale in seven existing European health care environments and accounts for the diversity in health system organisations and settings. Feasibility, health outcome and cost-effectiveness will be investigated. We will formulate European strategies for improving clinical implementation of pharmacogenomics based on the findings of this project.
Funded Companies:
| Company name | Funding amount |
| ACADEMISCH ZIEKENHUIS LEIDEN | €2,881,389 |
| BIO.LOGIS DIGITAL HEALTH GmbH | €118,901 |
| BIO.LOGIS GENETIC INFORMATION MANAGEMENT GmbH | €2,197,224 |
| BUNDESINSTITUT FUR ARZNEIMITTEL UND MEDIZINPRODUKTE | €214,325 |
| Centro Di Riferimento Oncologico Di Aviano | €875,380 |
| Institut National de la Sante et de la Recherche Medicale | €0.00 |
| Karolinska Institutet | €665,113 |
| KNMP HOLDING B.V. | €1,136,108 |
| Medizinische Universitaet Wien | €1,429,784 |
| Panepistimio Patron | €909,375 |
| ROBERT BOSCH GESELLSCHAFT FUR MEDIZINISCHE FORSCHUNG mbH | €561,394 |
| Royal Liverpool and Broadgreen University Hospitals NHS Trust | €0.00 |
| Servicio Andaluz de Salud | €810,938 |
| STEINBERGER DANIELA | €0.00 |
| STICHTING SINT ANTONIUS ZIEKENHUIS | €8,610.74 |
| The Golden Helix Foundation | €706,250 |
| The University of Liverpool | €1,078,330 |
| UNIVERSITAETSKLINIKUM AACHEN | €178,800 |
| UNIVERSITAIR MEDISCH CENTRUM UTRECHT | €159,229 |
| Universite Paul Sabatier Toulouse III | €280,055 |
| Univerza V Ljubljani | €430,825 |
| Uppsala Universitet | €294,584 |
Source: https://cordis.europa.eu/project/id/668353
The filing refers to a past date, and does not necessarily reflect the current state.